23andMe, a once highly valued genetics company, has suffered a dramatic decline in its market cap, falling from a $6 billion valuation to nearly zero. The company's stock has plummeted by 98%, and it faces the risk of running out of cash by 2025. Additionally, 23andMe is embroiled in multiple class action lawsuits and regulatory challenges. Despite its initial success and celebrity endorsements, the company's future appears uncertain, with its CEO, Anne Wojcicki, attempting to navigate a potential turnaround amidst significant setbacks.
The rise and fall of consumer genetics company 23andMe. https://t.co/6OM9zNz2qc
Shares of 23andMe closed at around $0.69 today, down 96% from their high three years ago. I spoke with CEO Anne Wojcicki about her plans to save the DNA-testing company. https://t.co/dY2vEEMC2G
23andMe’s Fall From $6 Billion to Nearly $0 https://t.co/YZ6aMtV6m3
Wow, genomic data is actually pretty worthless. 😮 https://t.co/rZRkf66bA7
23andme is in deep trouble, struggling to make a profit, 5 years after being insanely hyped.
23andMe was once one of the world’s hottest tech startups. Now it’s virtually worthless. @RolfeWinkler interviewed more than 50 people familiar with the company, including its CEO. He's answering your questions on Reddit 👇 https://t.co/xfCoozEBdP
23andMe's share price keeps on falling in the wake of hacks and losses https://t.co/0LkiaXdRsQ
pretty much "23andMe’s Fall From $6 Billion to Nearly $0" $me https://t.co/gWxxplNQfk https://t.co/S5gydCxte0
Fascinating fall from grace story about 23andMe $ME with all the usual drama including the unexpected firing of a co-founder: https://t.co/TgoEVmb1JR by @RolfeWinkler
This take is a little dismissive of the regulatory pressure faced by 23andMe. They wanted to provide consumers health information, and were stopped from doing so not on the basis of the info being poor quality Duke University bioethicist Nita A. Farahany: https://t.co/495na5oxOO https://t.co/ZUcP4mIySO https://t.co/CNM6mVfbMx
“23ANDME HAS LOST BILLIONS, ALMOST WORTHLESS NOW” Article: https://t.co/FhXi8qmAtT
Ouch. “Sequoia, which invested $145 million in 23andMe, still holds all its shares, he said. Today they are worth $18 million. “ https://t.co/4TvrqI7kAj
23andMe's Fall From $6 Billion to Nearly $0 - WSJ https://t.co/KFcnqtWLht
WSJ: 23andMe’s Fall From $6 Billion to Nearly $0 🤷♂️ https://t.co/nz6wUsGjmC
23andMe was once one of the hottest startups. Now it’s virtually worthless. https://t.co/EIzmLFB9Aw via @WSJ
23andMe has fallen from a $6 billion valuation to nearly $0 That's a valuation collapse of 98% from its peak in 2021 🗞️: @WSJ https://t.co/W66w5cyf3f
Once valued at $6 billion, 23andMe now faces multiple class action suits and a possible stock delisting. https://t.co/iONMNgvhgP
Oprah named 23andMe’s DNA-testing kit one of her favorite things. Lizzo dressed up as one for Halloween. Eddie Murphy name-checked the company on “Saturday Night Live.” It was once one of the world’s hottest startups. Now it’s virtually worthless. https://t.co/ZW8X02F0yY
23andMe Has Lost Billions, Almost Worthless Now https://t.co/V9v5SG6JLj
#23andMe valuation Fall From $6 Billion to Nearly $0. Another blow to a Silicon Valley blin-bling saga. Fascinating story tho. https://t.co/oO3FoH95QZ
Thanks for playing 23andMe’s Fall From $6 Billion to Nearly $0 https://t.co/pbXondOBV9
Really nice walk through the rise and fall and rise and fall and ???? of @23andMe from @RolfeWinkler. https://t.co/X1pQ3qf6uV The best part? https://t.co/MPPkyNXZNQ
23andMe faces lawsuit as hackers sell information on users with Jewish heritage https://t.co/5iPGjMHwIv
23andMe's Fall From $6 Billion To Nearly $0 https://t.co/pjYHHB2DvS
"23andMe’s Fall From $6 Billion to Nearly $0" https://t.co/xWtwTiNA3d This is a really interesting article. It's a shame that their really cool product may lack a "business case." Wojcicki (about whom I knew nothing) seems decent enough for a big-ego Silicon Valley-type, lol.
Few companies have betrayed their own users as badly as 23andMe. https://t.co/pnamO42r7f
$ME 23andMe’s Fall From $6 Billion to Nearly $0 - WSJ https://t.co/z3GN9JQww3
23andMe's stock, which hit a $6B valuation after a 2021 IPO, has crashed 98% and 23andMe may run out of cash by 2025, as CEO Anne Wojcicki plots a turnaround (@rolfewinkler / Wall Street Journal) https://t.co/AIcVsVDbhh https://t.co/35QKEAppLX
23andMe was once one of the hottest startups. Now it’s virtually worthless. https://t.co/Zqcxf4ZvEH
What happened 23andme? By @RolfeWinkler From $6 billion market cap to nearly zero. Very well reported and very well told. @WSJ https://t.co/bt7zwto9he
There's another class action lawsuit against 23andMe. The plaintiffs specifically mention the fact that the first leaked data targeted people with Ashkenazi Jewish and Chinese heritage, and that 23andMe didn't notify these victims sooner. https://t.co/Qy6dgeIfGv
A new lawsuit accuses 23andMe of failing to protect the privacy of customers whose data were exposed during a breach last year. Today's Readout newsletter: https://t.co/Dl36E0s9K5